MedTrace Logo

Palliative Care Outcomes in the Management of Malignant Ascites by Interventional Radiology

NCT02477657 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2022-01-12

No results posted yet for this study

Summary

Malignant ascites leads to significant morbidity in patients with terminal cancer. Paracentesis can provide relief, but repeat hospital visits, pain, and short duration of relief after paracentesis are detrimental to quality of life(QOL). Two devices are available as alternatives to paracentesis. The impact of either device on QOL has not fully been explored. A pilot nonrandomized trial measuring palliative care QOL and ascites symptom relief using validated survey instruments is proposed.

Conditions

  • Refractory Malignant Ascites

Interventions

PROCEDURE

Paracentesis

Paracentesis

DEVICE

Tunneled Intraperitoneal Drain (IPD)

Tunneled Intraperitoneal Drain (IPD)

DEVICE

Peritoneal-Venous shunts (PVS)

Peritoneal-Venous shunts (PVS)

Sponsors & Collaborators

  • Abramson Cancer Center at Penn Medicine

    lead OTHER

Principal Investigators

  • Gregory Nadolski, MD · Abramson Cancer Center at Penn Medicine

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2021-07-31
Primary Completion
2022-07-31
Completion
2023-07-31

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02477657 on ClinicalTrials.gov